HPS-148 - Fluconazole as an alternative in Cushing’s syndrome: A 10-year retrospective cohort

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-148
• By: HSIEH, Yen-Ju (Department of Pharmacy, Taipei Veterans General Hospital, China Taiwan)
• Co-author(s): Ms Yen-Ju Hsieh (Department of Pharmacy, Taipei Veterans General Hospital, Taipei City, China Taiwan)
  
• Abstract:

  Introduction
  
  Endogenous Cushing's syndrome (CS) is a rare endocrine disorder defined by prolonged hypercortisolism, affecting 2-8 per million people yearly. It significantly increases morbidity and mortality rates (standardized mortality ratio 3.0, 95% CI 2.3-3.9). CS originates from pituitary tumours (Cushing's disease, 60-70%), adrenal tumours..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login